Invus Public Equities Advisors, LLC
SEC CIK 1340096 · EDGAR
BoughtSold
Most active insiders at SRRK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | AKKARAJU SRINIVAS | Dir | $19.99M | — |
| 2 | Qatanani Mo | CSO | — | $8.60M |
| 3 | Hallal David | CEO, Dir | — | $3.97M |
| 4 | Vaishnaw Akshay | Pres of R, D, Dir | — | $1.48M |
| 5 | Sinha Vikas | CFO | — | $1.23M |
| 6 | Woods Keith | COO | — | $1.22M |
| 7 | Ho Junlin | GC | — | $802.3K |
| 8 | Parlavecchio Caryn | CHRO | — | $714.0K |
| 9 | Marantz Jing L. | Chief Medical Off | — | $451.3K |
| 10 | Peng Katie | Dir | — | $337.8K |
Invus Public Equities Advisors, LLC made no open-market trades at SRRK in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-11-27 | 2024-11-25 | SRRK | Scholar Rock Holding Corp | Invus Public Equities Advisors, LLC | 10% | S - Sale | $38.49 | -409.4K | 10.85M | -4% | -$15.76M |
| M | 2024-08-07 | 2024-08-05+ | CBIO | CRESCENT BIOPHARMA, INC. | Invus Public Equities Advisors, LLC | 10% | S - Sale | $0.1875 | -220.3K | 6.64M | -3% | -$41.3K |
| M | 2022-10-07 | 2022-10-03+ | SRRK | Scholar Rock Holding Corp | Invus Public Equities Advisors, LLC | 10% | P - Purchase | $7.60 | +100.0K | 8.78M | +1% | +$759.6K |
Purchase Sale Sale after option exercise All abbreviations